{
    "Trade/Device Name(s)": [
        "Detectabuse\u00ae Stat-Skreen Liquid Control Urine",
        "Detectabuse\u00ae Liquid Control Urine",
        "AU/NZ Detectabuse\u00ae Liquid Control Urine",
        "Immunoassay Series Detectabuse\u00ae Liquid Control Urine",
        "Confirm Series Detectabuse\u00ae Liquid Control Urine",
        "GC/MS Detectabuse\u00ae Liquid Control Urine Series",
        "Detectabuse\u00ae Liquid Control Urine Series, Single or Multi-Constituent"
    ],
    "Submitter Information": "Biochemical Diagnostics, Inc.",
    "510(k) Number": "K153474",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121122"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "December 3, 2015",
    "Summary Letter Received Date": "December 4, 2015",
    "Submission Date": "January 15, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Delta-9-THC-COOH",
        "Benzoylecgonine",
        "Phencyclidine (PCP)",
        "Morphine",
        "Morphine-3-glucuronide",
        "6-Monoacetylmorphine (6-MAM)",
        "Codeine",
        "Oxycodone",
        "Buprenorphine",
        "Fentanyl",
        "d-Amphetamine",
        "d-Methamphetamine",
        "3,4-Methylenedioxymethamphetamine (MDMA)",
        "3,4-Methylenedioxyamphetamine (MDA)",
        "3,4-Methylenedioxy-N-ethylamphetamine (MDEA)",
        "Secobarbital",
        "Phenobarbital",
        "Butalbital",
        "Oxazepam",
        "Nordiazepam",
        "Methadone",
        "EDDP",
        "Methaqualone",
        "Propoxyphene",
        "Norpropoxyphene",
        "Nortriptyline",
        "Cotinine",
        "Ethanol",
        "Amphetamines",
        "Cannabinoids",
        "Opiates",
        "Barbiturates",
        "Benzodiazepines",
        "Hydrocodone",
        "Buprenorphine Glucuronide",
        "Lysergic Acid",
        "Acetaminophen",
        "Tramadol",
        "Creatinine",
        "pH",
        "Specific Gravity",
        "Lorazepam",
        "MDMA",
        "MDEA",
        "MDA"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Immunoassay analyzer",
        "Roche Cobas 6000 analyzer",
        "Immunoassay single use screening devices"
    ],
    "Method(s)/Technology(ies)": [
        "GC/MS",
        "LC/MS",
        "Immunoassay screening"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Detectabuse\u00ae Liquid Control Urine series as quality control material for laboratory urine toxicology testing procedures",
    "Indications for Use Summary": "Intended for use as quality control urine to monitor precision and detect systematic deviations in laboratory urine toxicology testing procedures for multiple drug and analyte constituents",
    "fda_folder": "Toxicology"
}